Anna Sutherland

has published 3 posts

Anna Sutherland, BSc, MBChB(Hons), MRCP (UK), PG Cert Med Ed, FHEA, has previously been a Cochrane UK Fellow and is currently an ST5 in Palliative Medicine. Anna has undertaken a Cochrane Review and established the Cochrane UK Trainee Advisory Committee (CUKI-TAG). Anna's main interest is in improving the quality of patient care at the end of life, with a particular interest in the evidence based use of emerging pharmacological therapies. Anna also enjoys spending time with her twin daughters and young son.

Author Archives: Anna Sutherland

Cancer

Muddled by Mu-Opioid Antagonists for Opioid-Induced Constipation? Me too…

Anna Sutherland, palliative medicine doctor, looks at Cochrane evidence on the effectiveness and safety of mu-opioid antagonists for managing opioid-induced constipation in people with cancer and people receiving palliative care for whom laxatives have failed.